VERACYTE, INC. — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2021-02-26

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-26	Common Stock	A	12500	—	Acquired	80764	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Stock Option (right to buy)	$58.06	A	25000	Acquired	2031-02-26	Common Stock (25000.0)	Direct

Footnotes

F1: Restricted stock units awarded on February 26, 2021 vest 25% on March 2, 2022 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

F2: The option becomes exercisable as to 25% of the shares on February 26, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.